Cargando…
Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions
Since Huggins defined the androgen-sensitive nature of prostate cancer (PCa), suppression of systemic testosterone (T) has remained the most effective initial therapy for advanced disease although progression inevitably occurs. From the inception of clinical efforts to suppress androgen receptor (AR...
Autores principales: | Mohammad, Osama S., Nyquist, Michael D., Schweizer, Michael T., Balk, Stephen P., Corey, Eva, Plymate, Stephen, Nelson, Peter S., Mostaghel, Elahe A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742814/ https://www.ncbi.nlm.nih.gov/pubmed/29210989 http://dx.doi.org/10.3390/cancers9120166 |
Ejemplares similares
-
Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023) -
Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer
por: Lam, Hung-Ming, et al.
Publicado: (2018) -
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome
por: Qiu, Xintao, et al.
Publicado: (2022) -
The effects of supraphysiological levels of testosterone on neural networks upstream of gonadotropin-releasing hormone neurons
por: Salehi, Mohammad Saied, et al.
Publicado: (2019) -
Harnessing Solute Carrier Transporters for Precision Oncology
por: Nyquist, Michael D., et al.
Publicado: (2017)